| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Hemogenyx Pharmaceuticals Plc (LSE: HEMO)
HEMO Technical Analysis
5
| As on 22nd Nov 2024 HEMO STOCK Price closed @ 1.20 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.05 & Strong Sell for SHORT-TERM with Stoploss of 1.55 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HEMOSTOCK Price
| Open | 1.75 | Change | Price | % |
| High | 1.92 | 1 Day | -0.32 | -21.05 |
| Low | 0.88 | 1 Week | 0.04 | 3.45 |
| Close | 1.20 | 1 Month | -0.10 | -7.69 |
| Volume | 101610043 | 1 Year | -0.21 | -14.89 |
| 52 Week High 3.96 | 52 Week Low 1.05 | ||||
LSE UK Most Active Stocks
| NTOG | 0.02 | 0.00% |
| CPX | 0.14 | 7.69% |
| MSMN | 0.04 | 0.00% |
| VELA | 0.01 | % |
| TRP | 0.03 | % |
| SCGL | 0.27 | 92.86% |
| DKE | 0.15 | 0.00% |
| NNN | 0.09 | 50.00% |
| DMTR | 0.03 | 0.00% |
| VAST | 0.08 | 14.29% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
| HEMO Daily Charts |
HEMO Intraday Charts |
Whats New @ Bazaartrend |
HEMO Free Analysis |
|
|
HEMO Important Levels Intraday
| RESISTANCE | 3.20 |
| RESISTANCE | 2.56 |
| RESISTANCE | 2.16 |
| RESISTANCE | 1.77 |
| SUPPORT | 0.63 |
| SUPPORT | 0.24 |
| SUPPORT | -0.16 |
| SUPPORT | -0.80 |
HEMO Forecast November 2024
| 4th UP Forecast | 1.95 |
| 3rd UP Forecast | 1.71 |
| 2nd UP Forecast | 1.56 |
| 1st UP Forecast | 1.41 |
| 1st DOWN Forecast | 0.99 |
| 2nd DOWN Forecast | 0.84 |
| 3rd DOWN Forecast | 0.69 |
| 4th DOWN Forecast | 0.45 |
HEMO Weekly Forecast
| 4th UP Forecast | 2.59 |
| 3rd UP Forecast | 2.14 |
| 2nd UP Forecast | 1.87 |
| 1st UP Forecast | 1.59 |
| 1st DOWN Forecast | 0.81 |
| 2nd DOWN Forecast | 0.53 |
| 3rd DOWN Forecast | 0.26 |
| 4th DOWN Forecast | -0.19 |
HEMO Forecast2024
| 4th UP Forecast | 13.24 |
| 3rd UP Forecast | 9.38 |
| 2nd UP Forecast | 6.99 |
| 1st UP Forecast | 4.61 |
| 1st DOWN Forecast | -2.21 |
| 2nd DOWN Forecast | -4.59 |
| 3rd DOWN Forecast | -6.98 |
| 4th DOWN Forecast | -10.84 |
Hemogenyx Pharmaceuticals Plc ( LSE UK Symbol : HEMO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
HEMO Business Profile
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. The company is developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML), subset of acute lymphoblastic leukaemia, and myelodysplastic syndrome conditioning bone marrow transplants to substitute traditional chemotherapy and/or radiation; CAR-T therapy, a chimeric antigen receptor T-cells for use in immunotherapy, as well as for R/R AML; and Human Postnatal Hemogenic Endothelial Cells, a stem cell therapy product for BM/HSC transplants. Hemogenyx Pharmaceuticals Plc has a collaboration with GlobalCo. The company was incorporated in 2013 and is headquartered in London, the United Kingdom. Address: 5 Fleet Place, London, United Kingdom, EC4M 7RD
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service